pau d'arco taheebo
Selected indexed studies
- Safety and tolerability of Pau d' Arco (Tabebuia avellanedae) for primary dysmenorrhea: A single-arm, open-label trial on adults ages 18-45. (Adv Integr Med, 2022) [PMID:36960315]
- Single Dose Administration of Taheebo Polyphenol Enhances Endurance Capacity in Mice. (Sci Rep, 2018) [PMID:30279507]
- Tabebuia impetiginosa: A Comprehensive Review on Traditional Uses, Phytochemistry, and Immunopharmacological Properties. (Molecules, 2020) [PMID:32962180]
_Worker-drafted node — pending editorial review._
Connections
pau d'arco taheebo helps
Sources
- Safety and tolerability of Pau d' Arco (Tabebuia avellanedae) for primary dysmenorrhea: A single-arm, open-label trial on adults ages 18-45. (2022) pubmed
- Single Dose Administration of Taheebo Polyphenol Enhances Endurance Capacity in Mice. (2018) pubmed
- Tabebuia impetiginosa: A Comprehensive Review on Traditional Uses, Phytochemistry, and Immunopharmacological Properties. (2020) pubmed
- Growth inhibitory efficacy and anti-aromatase activity of Tabebuia avellanedae in a model for post-menopausal Luminal A breast cancer. (2019) pubmed
- Growth inhibition of estrogen receptor positive human breast cancer cells by Taheebo from the inner bark of Tabebuia avellandae tree. (2009) pubmed
- Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori. (2006) pubmed
- The anti-obesity effect of Taheebo (Tabebuia avellanedae Lorentz ex Griseb) extract in ovariectomized mice and the identification of a potential anti-obesity compound. (2016) pubmed
- Ethanolic extract of Taheebo attenuates increase in body weight and fatty liver in mice fed a high-fat diet. (2014) pubmed
- Development and Validation of an Analytical Method Readily Applicable for Quality Control of Tabebuia impetiginosa (Taheebo) Ethanolic Extract. (2018) pubmed
- Oral administration of taheebo (Tabebuia avellanedae Lorentz ex Griseb.) water extract prevents DSS-induced colitis in mice by up-regulating type II T helper immune responses. (2017) pubmed